Comparison of anti-PD-L1 with anti-PD-1 antibodies in the combination of HAIC and lenvatinib for the treatment of unresectable hepatocellular carcinoma.
JOURNAL OF CLINICAL ONCOLOGY（2023）
关键词
hepatocellular carcinoma,unresectable hepatocellular carcinoma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要